Evidence map›Paper›PMID 19365041›Full record

ReviewArchives of ophthalmology (Chicago, Ill. : 1960)2009

Stem cells as tools in regenerative therapy for retinal degeneration.

Volker Enzmann, Esma Yolcu, Henry J Kaplan, Suzanne T Ildstad

Abstract readReview
In one paragraph

Review in Archives of ophthalmology (Chicago, Ill. : 1960), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Potential of Müller Glial Cells in Regeneration of Retina; Clinical and Molecular Approach.International journal of organ transplantation medicine · 2022
    Review
  3. Article
  4. Review
  5. Retinal stem cell transplantation: Balancing safety and potential.Progress in retinal and eye research · 2020
    Review
  6. Review
  7. Article
  8. Advances in bone marrow stem cell therapy for retinal dysfunction.Progress in retinal and eye research · 2017
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Stem cell therapy for retinal diseases: update.Stem cell research & therapy · 2011
    Review
  17. A comparison of stem cells for therapeutic use.Stem cell reviews and reports · 2011
    Review
  18. Promises of stem cell therapy for retinal degenerative diseases.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2011
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Volker EnzmannDepartment of Ophthalmology, Inselspital, University of Bern, Bern, Switzerland.
Esma Yolcu
Henry J Kaplan
Suzanne T Ildstad
University Hospital of Bern · CH

Funding

Tolerance Induction to Islet TransplantsR01DK069766 · NIDDK · UNIVERSITY OF LOUISVILLE · PI ILDSTAD, SUZANNE T · 2005 to 2010
$1.6M
Mixed HSC Chimerism in Sensitized RecipientsR01HL063442 · NHLBI · UNIVERSITY OF LOUISVILLE · PI ILDSTAD, SUZANNE T · 2002 to 2005
$1.6M
NHLBI NIH HHS 5R01 HL063442NHLBI NIH HHS R01 HL063442NIDDK NIH HHS R01 DK069766
6 · The paper itself

Abstract

objectiveTo describe the use of stem cells (SCs) for regeneration of retinal degenerations. Regenerative medicine intends to provide therapies for severe injuries or chronic diseases where endogenous repair does not sufficiently restore the tissue. Pluripotent SCs, with their capacity to give rise to specialized cells, are the most promising candidates for clinical application. Despite encouraging results, a combination with up-to-date tissue engineering might be critical for ultimate success.

designThe focus is on the use of SCs for regeneration of retinal degenerations. Cell populations include embryonic, neural, and bone marrow-derived SCs, and engineered grafts will also be described.

resultsExperimental approaches have successfully replaced damaged photoreceptors and retinal pigment epithelium using endogenous and exogenous SCs.

conclusionsStem cells have the potential to significantly impact retinal regeneration. A combination with bioengineering may bear even greater promise. However, ethical and scientific issues have yet to be solved.

Indexed as

RegenerationStem Cell TransplantationAnimalsHumansPluripotent Stem CellsRegenerative MedicineRetinaRetinal DegenerationTissue Engineering

Identifiers

PMID19365041
PMCPMC3192438
OpenAlexW2152844611

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.